StockNews.com upgraded shares of Tactile Systems Technology (NASDAQ:TCMD – Free Report) from a buy rating to a strong-buy rating in a research note published on Friday.
Several other equities analysts have also recently issued reports on the company. Oppenheimer cut Tactile Systems Technology from an “outperform” rating to a “market perform” rating in a research report on Tuesday, November 5th. B. Riley initiated coverage on Tactile Systems Technology in a research report on Thursday, September 26th. They issued a “buy” rating and a $23.00 price objective for the company. Finally, BTIG Research lowered shares of Tactile Systems Technology from a “buy” rating to a “neutral” rating in a research report on Tuesday, November 5th.
View Our Latest Stock Report on TCMD
Tactile Systems Technology Stock Up 0.3 %
Institutional Trading of Tactile Systems Technology
Large investors have recently bought and sold shares of the company. Bank of New York Mellon Corp increased its stake in shares of Tactile Systems Technology by 14.6% during the 2nd quarter. Bank of New York Mellon Corp now owns 182,752 shares of the company’s stock worth $2,182,000 after purchasing an additional 23,296 shares in the last quarter. Bailard Inc. purchased a new stake in Tactile Systems Technology in the second quarter valued at approximately $260,000. Allspring Global Investments Holdings LLC increased its position in Tactile Systems Technology by 27.9% during the second quarter. Allspring Global Investments Holdings LLC now owns 33,373 shares of the company’s stock worth $398,000 after purchasing an additional 7,287 shares during the last quarter. Pinnacle Associates Ltd. raised its stake in Tactile Systems Technology by 324.9% during the second quarter. Pinnacle Associates Ltd. now owns 317,024 shares of the company’s stock worth $3,785,000 after purchasing an additional 242,413 shares during the period. Finally, Rhumbline Advisers grew its stake in shares of Tactile Systems Technology by 11.6% during the 2nd quarter. Rhumbline Advisers now owns 39,318 shares of the company’s stock valued at $469,000 after buying an additional 4,099 shares during the period. Institutional investors and hedge funds own 83.43% of the company’s stock.
Tactile Systems Technology Company Profile
Tactile Systems Technology, Inc, a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers.
Further Reading
- Five stocks we like better than Tactile Systems Technology
- ETF Screener: Uses and Step-by-Step Guide
- XPO Stock Gains Momentum as U.S. Trade Outlook Evolves
- How to Invest in Insurance Companies: A Guide
- CarMax Gets in Gear: Is Now the Time to Buy?
- The Role Economic Reports Play in a Successful Investment Strategy
- Qubit Combat: 2 Stocks Battle for Quantum Supremacy
Receive News & Ratings for Tactile Systems Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tactile Systems Technology and related companies with MarketBeat.com's FREE daily email newsletter.